Download presentation
Presentation is loading. Please wait.
Published byNorma Gray Modified over 9 years ago
1
1 Strategic Alliance With:Strategic Alliance in the U.K.With: 1 November 8, 2006 Amir Aviv Managing Director, International Corporate Finance Poalim Capital Markets Going Public Abroad – Key Considerations
2
2 Strategic Alliance With:Strategic Alliance in the U.K.With: 2 Table of Content A.Introduction to Poalim Capital Markets (PCM) B.Where to List? C.Listing Profiles and Shareholders Liquidity D.Relative Valuations Across Markets E.Liquidity - Nasdaq Vs. AIM F.Market Efficiency – Case Studies G.Comparative Costs
3
3 Strategic Alliance With:Strategic Alliance in the U.K.With: 3 Introduction to Poalim Capital Markets Introduction to Poalim Capital Markets
4
4 Strategic Alliance With:Strategic Alliance in the U.K.With: 4 Poalim Capital Markets - Overview Private Equity Local Underwriting Research International Corporate Finance Bank Hapoalim Holdings and Investments Poalim Abus Poalim Real Estate Poalim Mezzanine* Strategic Alliance Strategic Alliance (UK) Poalim Medica Poalim THTF * * Funds in formation Poalim Ventures
5
5 Strategic Alliance With:Strategic Alliance in the U.K.With: 5 Poalim Capital Markets Public Offerings 2005-2006 YTD November 2006 Initial Public Offering $47,500000 (U.K.) (USA) $160,000,000 May 2006 Initial Public Offering $132,000,000 March 2006 Follow- On Offering $201,100,000 December 2005 Follow-On Offering $133,831,000 September 2004 Follow-On Offering $401,280,000 March 2005 Follow-On Offering $64,400,000 March 2005 Initial Public Offering $62,400,000 September 2005 Initial Public Offering $118,000,000 November 2005 Initial Public Offering $191,000,000 February 2006 Initial Public Offering $90,000,000 May 2006 Initial Public Offering October 2006 Initial Public Offering $290,000000
6
6 Strategic Alliance With:Strategic Alliance in the U.K.With: 6 Poalim Capital Markets Advisory Services 2005-2006 YTD $7,000,000 April 2006 Invested in Has sold a majority interest to Fortissimo Capital and Kanir Investments $12,000,000 November 2005 Has acquired by Has agreed to be acquired by to York Capital Management and to Mivtach Shamir $67,851,000 July 2005 Selling of shares & debt in Inspair $2,300,000 May 2006 Invested in $159,000,000 July 2006 Has been acquired by $7,000,000 March 2006 Ziff Asset Management Invested in $7,000,000 July 2006 Sharatzky group Invested in $57,000,000 January 2005 Issued 11% of its shares capital to $54,000,000 January 2005 Sold 13% of to $90,000,000 March 2006 $230,000,000 November 2005 $60,500,000 April 2005 Has been acquired by $50,500,000 March 2005 Has been acquired by
7
7 Strategic Alliance With:Strategic Alliance in the U.K.With: 7 Where to List? Where to List?
8
8 Strategic Alliance With:Strategic Alliance in the U.K.With: 8 Valuation Metric used – Profit, Revenue, EBITDA, DCF, Revenue Multiples Forward Looking vs. Current Results Current Market Sentiment Sector Specific Sentiment Sector Performance Flavor of the Month Flow of Capital into Relevant Funds Research Following Location of revenues- Product Market Local Europe US Competitive Landscape- Listing Location Key Considerations – Company Specific Approach
9
9 Strategic Alliance With:Strategic Alliance in the U.K.With: 9 Size and Critical Mass Liquidity Percentage Float Sector Specific Form of Liquidity – open market, block sales Costs Capital at Risk Success Costs Maintenance Costs Regulation and Reporting Requirements Quarterly (Nasdaq, TASE) vs. Semi Annually (London) Dual-Listing Arrangements Profile as a Public Company Target Product Markets –Branding and Positioning Disclosure Requirements (Transparency) Location of Management and Operations Key Considerations – Company Specific Approach (cont’d)
10
10 Strategic Alliance With:Strategic Alliance in the U.K.With: 10 Listing Profiles and Shareholders Liquidity Listing Profiles and Shareholders Liquidity
11
11 Strategic Alliance With:Strategic Alliance in the U.K.With: 11 NASADQ IPOs Priced 2006 YTD * Columns represent stand-alone threshold data and are not interdependent Percentile Total Offering Size Market Value at pricing Ownership Dilution Secondary Shares as a % of Offering LTM Revenue LTM EBIT LTM EBIT Margin At Pricing P/E on Next Year’s Earnings 100% 2,579.3 6,016.1114.3%100.0%7,792.0497.0146.2%79.6x 90%481.61,705.642.8%47.3%942.367.627.1%25.9x 80%264.6994.535.3%26.0%385.739.614.2%18.9x 70%184.9536.830.2%16.2%285.223.010.2%16.0x 60%140.7383.827.4%0.0%176.212.07.0%14.0x 50%105.6306.423.8%0.0%85.54.86.2%12.5x 40%87.0269.920.3%0.0%43.31.14.2%10.8x 30%61.1218.118.3%0.0%30.9(0.7)1.3%8.8x 20%38.5140.014.4%0.0%14.9(10.7)(1.7%)-4.0x 10%25.484.50.0% 3.5(17.7)(47.5%)-13.5x ($ in millions) Source: Equidesk as of November 1, 2006; includes SEC registered IPOs; excludes REITs and closed-end funds.
12
12 Strategic Alliance With:Strategic Alliance in the U.K.With: 12 NASADQ - YTD Over 40% of IPO’s had a Secondary Share Component Source: Equidesk as of August 1, 2006; includes SEC registered IPOs; excludes REITs and closed-end funds.
13
13 Strategic Alliance With:Strategic Alliance in the U.K.With: 13 NASADQ - On Average < 30% of Shares Sold are Secondary Shares 33.6% 38.1% 26.6% 32.2% 23.2% 23.0% 38.1% 29.2% 21.0% Source: Equidesk as of November 1, 2006; includes SEC registered IPOs; excludes REITs and closed-end funds.
14
14 Strategic Alliance With:Strategic Alliance in the U.K.With: 14 AIM - Distribution of companies by equity market value Number of companies Market value range £m Source: LSE, as of November 2006
15
15 Strategic Alliance With:Strategic Alliance in the U.K.With: 15 Relative Valuations Across Markets Relative Valuations Across Markets
16
16 Strategic Alliance With:Strategic Alliance in the U.K.With: 16 Valuation Methodology Comment Relevance Preferred benchmark for IPOs reflecting investors’ preference for profitability Forward P/E Method Historically the standard valuation tool where lack of profits Used to review valuation levels across the cycle Forward EV / EBITDA Forward EV / sales Significant sensitivity to a number of assumptions Overly dependent on terminal value Often used as a “sanity check” DCF analysis Multiples DCF Not distorted by differences in capital structure Many technology companies still pre operating profit Key driver will be forward P/E
17
17 Strategic Alliance With:Strategic Alliance in the U.K.With: 17 Industry Benchmarking – Where are Your Competitors Trading? gross margin and growth rate support high value?
18
18 Strategic Alliance With:Strategic Alliance in the U.K.With: 18 LSE vs. NASDAQ Nasdaq Valuations are 20% Higher than AIM Across the Board *Sources – NASDAQ, LSE, CapitalIQ *Companies with market cap <1Bn USD as of September 2006
19
19 Strategic Alliance With:Strategic Alliance in the U.K.With: 19 LSE vs. NASDAQ - Healthcare Healthcare Companies Valuations on Nasdaq are 24% Higher than on AIM *Sources – NASDAQ, LSE, CapitalIQ *Companies with market cap <1Bn USD as of September 2006
20
20 Strategic Alliance With:Strategic Alliance in the U.K.With: 20 LSE vs. NASDAQ - IT IT Companies Valuations on Nasdaq are 28% Higher than on AIM *Sources – NASDAQ, LSE, CapitalIQ *Companies with market cap <1Bn USD as of September 2006
21
21 Strategic Alliance With:Strategic Alliance in the U.K.With: 21 LSE vs. NASDAQ – Industrial (%) Industrial Companies Valuations on Aim are 9% Higher than on Nasdaq *Sources – NASDAQ, LSE, CapitalIQ *Companies with market cap <1Bn USD as of September 2006
22
22 Strategic Alliance With:Strategic Alliance in the U.K.With: 22 Liquidity - NASDAQ Vs. AIM Liquidity - NASDAQ Vs. AIM
23
23 Strategic Alliance With:Strategic Alliance in the U.K.With: 23 Liquidity - NASDAQ vs. AIM Liquidity - NASDAQ vs. AIM Market Cap (mn USD) Number of Companies in Group - AIM Number of Companies in Group - Nasdaq AIM Avg. Daily Volume (USD – mn) Nasdaq Avg. Daily Volume (USD – mn) 0-507021840.0530.216 50-1502435600.3000.564 150-300964960.6911.850 300-500374331.1403.500 500+269457.62045.900 Liquidity on Nasdaq is better than on AIM across the board, however... Source: CapitalIQ
24
24 Strategic Alliance With:Strategic Alliance in the U.K.With: 24 Source: London Stock Exchange Liquidity on AIM is improving rapidly Liquidity - NASDAQ vs. AIM Liquidity - NASDAQ vs. AIM Average Daily Volume £mn
25
25 Strategic Alliance With:Strategic Alliance in the U.K.With: 25 Market Efficiency – Case Studies Market Efficiency – Case Studies
26
26 Strategic Alliance With:Strategic Alliance in the U.K.With: 26 Summary Ituran NASDAQ IPO completion date: September 27 th, 2005 Total funds raised at IPO and green-shoe: $71,760,000 At IPO: Net proceeds to selling shareholders: $11.7mn Green-shoe: Net proceeds to selling shareholders: $1.8mn Total funds to selling shareholders: $13.5mn 5 foreign I-banks cover Ituran with research Stock Price Performance on TASE 12 months before IPO to 3 months after Relative Price Appreciation 12 months prior to IPO to 3 months after Premium Analysis ITRN TA100 Nasdaq 3 months prior to IPO: 40.0% 6 months prior to IPO: 29.2% 9 months prior to IPO: 52.4% 12 months prior to IPO: 101.0% 3 months after the IPO to IPO price: 20.8%
27
27 Strategic Alliance With:Strategic Alliance in the U.K.With: 27 Summary Lipman NASDAQ IPO completion date: February 3 rd, 2004 Total capital raised at IPO and green-shoe: $142,395,000 At IPO: Net proceeds to selling shareholders: $29.3mn Green-shoe: Net proceeds to selling shareholders: $0mn Total funds to selling shareholders: $29.3mn 4 foreign I-banks cover Lipman with research Stock Price Performance on TASE 12 months before IPO to 3 months after Relative Price Appreciation 12 months prior to IPO to 3 months after Premium Analysis 3 months prior to IPO: 24.0% 6 months prior to IPO: 51.1% 9 months prior to IPO: 73.6% 12 months prior to IPO: 123.2% 3 months after the IPO to IPO price: 11% LPMA TA100 Nasdaq
28
28 Strategic Alliance With:Strategic Alliance in the U.K.With: 28 Summary Frutarom LSE IPO completion date: February 3 rd, 2005 Total funds raised at IPO and green-shoe: $100,716,000 At IPO: Net proceeds to selling shareholders: $15.3mn Green-shoe: Net proceeds to selling shareholders: $4.6mn Total funds to selling shareholders: $19.9mn 2 foreign I-banks provide Frutarom with research Stock Price Performance on TASE 12 months before IPO to 3 months after Relative Price Appreciation 12 months prior to IPO to 3 months after Premium Analysis LPMA TA100 Nasdaq 3 months prior to IPO: 30.3% 6 months prior to IPO: 31.3% 9 months prior to IPO: 59.2% 12 months prior to IPO: 82.3% 3 months after the IPO to IPO price: -3.4% FRUT TA100 Nasdaq
29
29 Strategic Alliance With:Strategic Alliance in the U.K.With: 29 Comparative Costs Comparative Costs
30
30 Strategic Alliance With:Strategic Alliance in the U.K.With: 30 Cost of Going Public ($US)NasdaqAIM Registration Fee~$5,500~$20,000 Listing Fee~$100,000~$6,000 Printing Expenses~$200,000~$60,000 Legal Fees~$500,000~$400,000 Accounting Fees~$500,000~$350,000 Transfer Agent & Registrar Fees ~$10,000~$15,000 Nomad/I-Bank Fee N/A~$300,000 Underwriting Discount*~$3,500,000 (~7%)~$2,500,000 (~5%) Miscellaneous~$100,000~$70,000 Total Approximate Cost~$4,915,500~$3,721,000 * Assumes a $50m dollar raise ** Capital at risk is approximately $400k, $220k on NASDAQ and AIM respectively
31
31 Strategic Alliance With:Strategic Alliance in the U.K.With: 31 Public Company Ongoing Costs ($US)NasdaqAIM Directors & Officers Insurance ~$200,000~$100,000 Directors Fees & Expenses~$150,000~$100,000 Annual Audit Accounting Fees ~$100,000~$80,000 404 Compliance*~$400,000N/A Legal Fees~$150,000 SEC & Exchange Compliance~$100,000N/A Listing Fees~$25,000~$20,000 Nomad ExpensesN/A~$90,000 Other (Investor Relations, Mailing, Printing, Trvl, etc.) ~$100,000 Total Approximate Cost$1,225,000$640,000 * 404 not applicable to foreign issuers until 2007. Varies depending on company size. ** Nasdaq incremental cost for TASE listed companies approx. $400-$600k based on survey of dual listed companies
32
32 Strategic Alliance With:Strategic Alliance in the U.K.With: 32 Thank You Contact Details: Amir Aviv Managing Director, International Corporate Finance Poalim Capital Markets Tel: (03) 567-5590 aaviv@poalimcm.com
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.